Trabajo Social en la Unidad de Cuidados Paliativos Pediátricos

Los Cuidados Paliativos Pediátricos (CPP) son una respuesta a las necesidades físicas, psicológicas, sociales y emocionales de los niños que presentan una enfermedad limitante, proporcionando la mayor calidad de vida posible. La atención a las necesidades sociales debe ser atendidas por el profesional del trabajo social, de este modo, el presente trabajo consiste en una revisión bibliográfica con el objetivo de visibilizar el papel que desempeña el profesional del trabajo social en la Unidad de Cuidados Paliativos Pediátricos.Departamento de Sociología y Trabajo SocialGrado en Trabajo Socia

El recurso humano en el éxito empresarial de la empresa Sodexo en el contrato argos planta Toluviejo periodo 2016-2017

La monografía titulada: “El recurso humano en el éxito empresarial de la empresa Sodexo en el contrato Argos planta Toluviejo periodo 2016-2017”, tiene como objeto general analizar cómo influye el desarrollo del recurso humano en el éxito empresarial y para lograrlo se formularon unos objetivos específicos que permitirán determinar cómo impactan los procesos de reclutamiento y selección del recurso humano, describir la importancia que tienen las actividades de formación y bienestar y los sistemas de incentivo en el éxito de las empresas con el fin de establecer la relación entre la calidad del recurso humano y el éxito empresarial. A través de todo el trabajo se busca explicar cómo la gestión planificada del recurso humano desde su proceso de reclutamiento y selección; pasando por un estructurado proceso de formación y un buen sistema de incentivos se convierten en factores fundamental para lograr éxito empresarial.The monograph entitled: "The human resource in the business success of the company Sodexo in the contract Argos plant Toluviejo period 2016-2017", has as its general objective to analyze how the development of human resources influences business success and to achieve this, some specific objectives to determine how the processes of recruitment and selection of human resources impact, describe the importance of training and welfare activities and incentive systems in the success of companies in order to establish the relationship between the quality of the human resource and business success. Through all the work we seek to explain how the planned management of human resources from their recruitment and selection process; going through a structured training process and good incentive systems become fundamental factors to achieve business success

Desenvolvimento da terapia assistida por animais na psicologia

Objective: It is necessary that professionals in psychology seek treatment alternatives that make more effective the various interventions with established traditional or alternative models to help improve the effectiveness of therapeutic treatment. The Animal Assisted Therapy is directed by health care providers or humans within the scope of their profession. This originates with the psychiatrist Boris Levison, who began building the foundation of the TAA. Among the research that has been conducted Engleman (2013) measured the effect that could have the integration of TAA in patients with pain under palliative treatment. Conclusions: In addition, in the field of psychotherapy TAA is intended as a supplement to different models. It is also important to emphasize that the TAA will maintain the structure of any process of psychotherapy, where there will be a psychotherapeutic alliance process, identifying problems to be treated and set goals.Objetivo: Es necesario que los profesionales de psicología busquen alternativas de tratamiento que hagan más efectivas las diferentes intervenciones con los modelos tradicionales ya establecidos o alternativas que ayuden a mejorar la efectividad del tratamiento terapéutico. La Terapia Asistida por Animales es dirigida por proveedores de servicios de salud o humanos bajo el ámbito de su profesión. Esta se origina con el psiquiatra Borris Levison, quien comenzó estableciendo las bases de la TAA. Entre las investigaciones que se han llevado a cabo Engleman (2013) midió el efecto que podía tener la integración de TAA en pacientes con dolor bajo tratamiento paliativo. Conclusiones: Por otro lado en el campo de la psicoterapia se plantea la TAA como un complemento a diferentes modelos. Además es importante enfatizar que la TAA mantendrá la estructura de cualquier proceso de psicoterapia, donde habrá un proceso alianza psicoterapéutica, identificar problemas a tratar y establecer metas.Objetivo: É necessário que os profissionais de psicologia procurem alternativas de tratamento que façam mais efetivas as diferentes intervenções com os modelos tradicionais já estabelecidos ou alternativas que ajudem a melhorar a efetividade do tratamento terapêutico. A Terapia Assistida por Animais é dirigida por fornecedores de serviços de saúde ou humanos sob o âmbito de sua profissão. Esta se origina com o psiquiatra Borris Levison, quem começou estabelecendo as bases da TAA. Entre as investigações que se levaram a cabo Engleman (2013) mediu o efeito que podia ter a integração de TAA em pacientes com dor sob tratamento paliativo. Conclusões: Por outro lado no campo da psicoterapia se propõe a TAA como um complemento a diferentes modelos. Ademais é importante enfatizar do que a TAA manterá a estrutura de qualquer processo de psicoterapia, onde terá um processo aliança psicoterapêutica, identificar problemas a tratar e estabelecer metas

Development of a tracking system of exotic nuclear beams for FAIR

New accelerators like SPIRAL2 (GANIL, France) or FAIR (GSI, Germany) will be soon constructed, and they will be able to produce radioactive ion beams (RIB) with high intensities of current (≥106pps). These beams, at low energy, lower than 20 MeV/n, usually have high emittance, which imposes the use of tracking detectors before the target in order to reconstruct the trajectory of the ions. The group of Nuclear Physics at CNA (Centro Nacional de Aceleradores), is in charge of developing a tracking system for the low energy branch of FAIR (the HISPEC/DESPEC project). A collaboration with CEA-SACLAY was established, with the aim of developing, building and testing low pressure Secondary electron Detectors (SeD). Within this proposal we have projected and constructed a new Nuclear Physics Line in the CNA in order to be able to receive any kind of detector tests and the associated nuclear instruments

Determinantes del Spread en las Tasas de Interés Bancarias en Costa Rica

Proyecto de graduación (Licenciatura en Administración de Empresas. Enfasis en Finanzas) Instituto Tecnológico de Costa Rica, Escuela de Administración de Empresas, 2016.Determine the factors that determine the Costa Rican banking spread, through an analysis of qualitative data with information from the Costa Rican financial system using the methodology used in similar other studies prepared for Latin America, which consist in analize the microeconomic, macroeconomic and institutional variables that theoretically affect the composition of the spread and compare it to the specific case of Costa Rica by an expert opinion. Also, this investigation made a comparison between the Costa Rican bank spread to other countries in the region between the period 2005 to 2014, in order to visualize the evolution that has taken this indicator in recent years was performed. This type of study could be useful to discern certain regulatory measures that can be applied in Costa Rica to improve financial intermediation margin.Instituto Tecnológico de Costa Rica

Distinct mutational pattern of myelodysplastic syndromes with and without 5q– treated with lenalidomide

Financial support: This work was supported in part by a grant from the Instituto de Salud Carlos III, Ministerio de Economia y Competividad, Spain (PI/14/00013; PI/17/0575); 2017 SGR288 (GRC) Generalitat de Catalunya, economical support from CERCA Program/Generalitat de Catalunya, Fundació Internacional Josep Carreras and from Celgene Spain. The research leading to this invention has received funding from ‘la Caixa’ Foundation. Laura Palomo and Jesus Maria Hernandez‐Sanchez are supported with a research grant by FEHH (Fundación Española de Hematología y Hemoterapia).Peer reviewe

Role of age and comorbidities in mortality of patients with infective endocarditis

[Purpose]: The aim of this study was to analyse the characteristics of patients with IE in three groups of age and to assess the ability of age and the Charlson Comorbidity Index (CCI) to predict mortality. [Methods]: Prospective cohort study of all patients with IE included in the GAMES Spanish database between 2008 and 2015.Patients were stratified into three age groups:<65 years,65 to 80 years,and ≥ 80 years.The area under the receiver-operating characteristic (AUROC) curve was calculated to quantify the diagnostic accuracy of the CCI to predict mortality risk. [Results]: A total of 3120 patients with IE (1327 < 65 years;1291 65-80 years;502 ≥ 80 years) were enrolled.Fever and heart failure were the most common presentations of IE, with no differences among age groups.Patients ≥80 years who underwent surgery were significantly lower compared with other age groups (14.3%,65 years; 20.5%,65-79 years; 31.3%,≥80 years). In-hospital mortality was lower in the <65-year group (20.3%,<65 years;30.1%,65-79 years;34.7%,≥80 years;p < 0.001) as well as 1-year mortality (3.2%, <65 years; 5.5%, 65-80 years;7.6%,≥80 years; p = 0.003).Independent predictors of mortality were age ≥ 80 years (hazard ratio [HR]:2.78;95% confidence interval [CI]:2.32–3.34), CCI ≥ 3 (HR:1.62; 95% CI:1.39–1.88),and non-performed surgery (HR:1.64;95% CI:11.16–1.58).When the three age groups were compared,the AUROC curve for CCI was significantly larger for patients aged <65 years(p < 0.001) for both in-hospital and 1-year mortality. [Conclusion]: There were no differences in the clinical presentation of IE between the groups. Age ≥ 80 years, high comorbidity (measured by CCI),and non-performance of surgery were independent predictors of mortality in patients with IE.CCI could help to identify those patients with IE and surgical indication who present a lower risk of in-hospital and 1-year mortality after surgery, especially in the <65-year group

Indigenous Peoples and local communities report ongoing and widespread climate change impacts on local social-ecological systems

The effects of climate change depend on specific local circumstances, posing a challenge for worldwide research to comprehensively encompass the diverse impacts on various local social-ecological systems. Here we use a place-specific but cross-culturally comparable protocol to document climate change indicators and impacts as locally experienced and analyze their distribution. We collected first-hand data in 48 sites inhabited by Indigenous Peoples and local communities and covering all climate zones and nature-dependent livelihoods. We documented 1,661 site-agreed reports of change corresponding to 369 indicators. Reports of change vary according to climate zone and livelihood activity. We provide compelling evidence that climate change impacts on Indigenous Peoples and local communities are ongoing, tangible, widespread, and affect multiple elements of their social-ecological systems. Beyond potentially informing contextualized adaptation plans, our results show that local reports could help identify economic and non-economic loss and damage related to climate change impacts suffered by Indigenous Peoples and local communities

Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial

Background: Tranexamic acid reduces surgical bleeding and reduces death due to bleeding in patients with trauma. Meta-analyses of small trials show that tranexamic acid might decrease deaths from gastrointestinal bleeding. We aimed to assess the effects of tranexamic acid in patients with gastrointestinal bleeding. Methods: We did an international, multicentre, randomised, placebo-controlled trial in 164 hospitals in 15 countries. Patients were enrolled if the responsible clinician was uncertain whether to use tranexamic acid, were aged above the minimum age considered an adult in their country (either aged 16 years and older or aged 18 years and older), and had significant (defined as at risk of bleeding to death) upper or lower gastrointestinal bleeding. Patients were randomly assigned by selection of a numbered treatment pack from a box containing eight packs that were identical apart from the pack number. Patients received either a loading dose of 1 g tranexamic acid, which was added to 100 mL infusion bag of 0·9% sodium chloride and infused by slow intravenous injection over 10 min, followed by a maintenance dose of 3 g tranexamic acid added to 1 L of any isotonic intravenous solution and infused at 125 mg/h for 24 h, or placebo (sodium chloride 0·9%). Patients, caregivers, and those assessing outcomes were masked to allocation. The primary outcome was death due to bleeding within 5 days of randomisation; analysis excluded patients who received neither dose of the allocated treatment and those for whom outcome data on death were unavailable. This trial was registered with Current Controlled Trials, ISRCTN11225767, and ClinicalTrials.gov, NCT01658124. Findings: Between July 4, 2013, and June 21, 2019, we randomly allocated 12 009 patients to receive tranexamic acid (5994, 49·9%) or matching placebo (6015, 50·1%), of whom 11 952 (99·5%) received the first dose of the allocated treatment. Death due to bleeding within 5 days of randomisation occurred in 222 (4%) of 5956 patients in the tranexamic acid group and in 226 (4%) of 5981 patients in the placebo group (risk ratio [RR] 0·99, 95% CI 0·82–1·18). Arterial thromboembolic events (myocardial infarction or stroke) were similar in the tranexamic acid group and placebo group (42 [0·7%] of 5952 vs 46 [0·8%] of 5977; 0·92; 0·60 to 1·39). Venous thromboembolic events (deep vein thrombosis or pulmonary embolism) were higher in tranexamic acid group than in the placebo group (48 [0·8%] of 5952 vs 26 [0·4%] of 5977; RR 1·85; 95% CI 1·15 to 2·98). Interpretation: We found that tranexamic acid did not reduce death from gastrointestinal bleeding. On the basis of our results, tranexamic acid should not be used for the treatment of gastrointestinal bleeding outside the context of a randomised trial